Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Operations Statements (unaudited)

v3.19.3.a.u2
Condensed Consolidated Operations Statements (unaudited) - USD ($)
3 Months Ended 6 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2019
Oct. 31, 2018
Income Statement [Abstract]        
REVENUES
EXPENSES        
Research and development 76,724 112,096 262,419 219,264
General and administrative expenses 139,397 45,785 275,204 84,567
Loss before income taxes 216,121 157,881 537,623 303,831
Provision for income taxes
NET LOSS $ 216,121 $ 157,881 $ 537,623 $ 303,831
LOSS PER SHARE - basic and diluted $ (0.01) $ (0.88) $ (0.06) $ (1.70)
Weighted average shares outstanding - basic and diluted 16,929,048 179,293 8,644,382 179,202